Johnson joins ‘Dream Team’ of scientists collaborating on rare pediatric cancer

Johnson joins ‘Dream Team’ of scientists collaborating on rare pediatric cancer
click to enlarge
Dr. Gary Johnson

UNC Lineberger member Gary Johnson, PhD, professor and chair of the UNC Department of Pharmacology, has been tapped to join Synodos, a team of scientists working together to defeat the rare genetic disorder neurofibromatosis type 2 (NF2). A first-of-its-kind NF research collaboration, Synodos has brought together centers of excellence from institutions across the country. Johnson will be just one of 12 academic researchers in the collaboration. (excerpt from UNC Lineberger Comprehensive Cancer Center news article by Katie A. Jones, April 11, 2014.)

Read the full article on the Lineberger news site.